Share Email Print

Proceedings Paper

Photodynamic therapy as an adjuvant intraoperative treatment of recurrent head and neck carcinomas
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

Despite aggressive surgical and radiotherapy, recurrence rates for patients with recurrent head and neck carcinomas remain high. Photodynamic therapy has been successfully used to treat patients with early carcinomas. This is due to the ability of the activating laser light to penetrate up to one centimeter into tissue, resulting in destruction of microscopic tumor with preservation of normal tissues. Employing this principle, PDT was used as an adjuvant intraoperative therapy following resection of tumor in five patients with recurrent infiltrating carcinomas of the head and neck. All patients tolerated the treatment without complications and all but one remains free of disease twenty-four months post-treatment. Adjuvant intraoperative PDT may improve cure rates of recurrent head and neck malignancies by providing for larger tumor-free margins of resection while preserving normal structures.

Paper Details

Date Published: 12 May 1995
PDF: 4 pages
Proc. SPIE 2395, Lasers in Surgery: Advanced Characterization, Therapeutics, and Systems V, (12 May 1995); doi: 10.1117/12.209106
Show Author Affiliations
Merrill A. Biel M.D., Minneapolis Ear, Nose and Throat Clinic (United States)

Published in SPIE Proceedings Vol. 2395:
Lasers in Surgery: Advanced Characterization, Therapeutics, and Systems V
R. Rox Anderson M.D.; Graham M. Watson M.D.; Rudolf W. Steiner; Douglas E. Johnson M.D.; Stanley M. Shapshay M.D.; Michail M. Pankratov; George S. Abela M.D.; Lawrence S. Bass M.D.; John V. White M.D.; Rodney A. White M.D.; Kenneth Eugene Bartels D.V.M.; Lloyd P. Tate V.D.M.; C. Thomas Vangsness M.D., Editor(s)

© SPIE. Terms of Use
Back to Top
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?